KBC Group’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,390
Closed -$28K 1844
2024
Q1
$28K Hold
2,390
﹤0.01% 1785
2023
Q4
$17K Sell
2,390
-819
-26% -$6.46K ﹤0.01% 1855
2023
Q3
$29K Sell
3,209
-3,200
-50% -$38.4K ﹤0.01% 1791
2023
Q2
$78K Hold
6,409
﹤0.01% 1254
2023
Q1
$80K Hold
6,409
﹤0.01% 1271
2022
Q4
$123K Hold
6,409
﹤0.01% 1131
2022
Q3
$120K Buy
+6,409
New +$132K ﹤0.01% 1112

Other funds holding AHCO

KBC Group's AHCO Position: Q2 2024 in Review

KBC Group sold out of AdaptHealth (AHCO) in Q2 2024, closing a stake of 2,390 shares — an estimated $28K sold.

KBC Group first reported a position in AHCO in Q3 2022 and held it in 7 quarters. The position peaked at $123K in Q4 2022. 207 funds tracked by Wall St. Rank hold AHCO as of Q2 2024.

  • KBC Group reported no remaining AdaptHealth position as of Q2 2024 after selling out during the quarter.
  • KBC Group sold 2,390 AdaptHealth shares in Q2 2024, an estimated $28K.
  • KBC Group first reported a position in AdaptHealth in Q3 2022 and held it in 7 quarters.
  • KBC Group's AdaptHealth position peaked at $123K in Q4 2022.
  • 207 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2024.

Based on KBC Group's 13F filing for Q2 2024, filed 17 Jul 2024.